medical device investing Accuray and the University of Wisconsin-Madison Announce Master Research Agreement to Improve Personalized Care for Patients with Cancer
medical device investing Accuray to Report Third Quarter Fiscal 2026 Financial Results on May 6, 2026
medical device investing Accuray Appoints Paul Miele as Senior Vice President and Chief Commercial Officer
medical device investing Accuray Appoints Paul Miele as Senior Vice President and Chief Commercial Officer
medical device investing Accuray to Report Second Quarter Fiscal 2026 Financial Results on February 4, 2026
medical device investing Accuray announces first phase of comprehensive strategic, operational, and organizational transformation plan; company expects first phase to improve annualized operating profitability by approximately $25 million and set the stage for renewed growth
medical device investing Accuray to Report First Quarter Fiscal 2026 Financial Results on November 5, 2025
medical device investing Accuray Announces Milestone for Cancer Patients in Melbourne, Australia with First SBRT Treatments Using the CyberKnife® System
medical device investing Accuray and the University of Wisconsin-Madison Announce Memorandum of Understanding to Advance Online Adaptive Radiotherapy in Support of Improving Cancer Patient Care
Blue Jay Gold Corp. Announces Engagement of Oak Hill Financial Inc. for Investor Relations and Retention of Haywood Securities for Market Making Services
QIMC Highlights Technical Advisory Role on First Atlas Matane Natural Hydrogen Project Following Quebec Parliamentary Committee Appearance
